In the wake of the tragedy in Bend, OHSU official urge community members to safely store firearms in their homes, especially if there are children present. Shereef Elnahal, M.D., says the Tom Sargent Safety Center can offer safety consultations to anyone in the state, and provides firearm storage options at a discount.

The annual Doernbecher Freestyle auction, featuring custom Nike shoes designed by six pediatric patients, raised a record-breaking $2.4 million to support OHSU Doernbecher Children’s Hospital, including patient care, research initiatives and plans for an expanded neonatal and maternal-child services. Dana Braner, M.D., says, “A founding principle of Doernbecher was that it would be a lifesaving resource for kids and their families, regardless of their ability to pay. And that principle has become a promise that still stands firm today, thanks in huge part to the continuous support we receive from the community.”

OHSU is mentioned in dozens of stories by hundreds of news outlets covering developments following the tragedy at the Bend elementary school.

OHSU is mentioned in dozens of stories by hundreds of news outlets covering developments following the tragedy at the Bend elementary school.

OHSU study that finds late-night snacking could lead to increased risk of fatty liver disease and cirrhosis.

Technology Networks covers new study that finds Oregon’s licensed psilocybin centers generally follow state-mandated safety screening requirements, though high costs remain a barrier for many prospective patients, noting that the findings complement a recent OHSU study in which serious adverse reactions among 346 Oregon clients were uncommon.

A Portland Business Journal profile of business leaders’ experiences managing breast cancer diagnoses and treatment while continuing to lead in demanding professional roles highlights OHSU’s research and clinical care in breast cancer.

Media cover a new labor guide from OHSU to help combat misinformation. Sam Melville, M.D., says, “In an era where we are seeing a lot more misinformation on social media, patients getting misinformation from AI, we are trying to support our ability to provide evidence-based information.”

Medscape covers an early trial of Tilrekimig for people with eczema. Eric Simpson, M.D., says, “We still have patients who have inadequate responses and potential adverse events to the current biologics. So there’s still a lot of development going on in atopic dermatitis, which I think rightly so.”

HealthDay highlights a review that shows mifepristone prevents more pregnancies and has fewer side effects than other emergency contraception options. Shaalini Ramanadhan, M.D., says, “As an anti-progestin, it works differently than the other steroid hormone-based methods like levonorgestrel and combined estrogen and progestin pills to delay or block ovulation.”